Parker Institute For Cancer Immunotherapy
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2015 | 73,509,764 | 69,207,119 | 4,302,645 | 0.8 | 2% |
| 2016 | 39,900,210 | 39,104,869 | 795,341 | 1.7 | 16% |
| 2017 | 65,939,195 | 54,685,666 | 11,253,529 | 3.7 | 18% |
| 2018 | 113,439,151 | 66,202,166 | 47,236,985 | 11.6 | 21% |
| 2019 | 162,648,564 | 77,964,615 | 84,683,949 | 22.9 | 19% |
| 2020 | 66,027,113 | 69,855,756 | −3,828,643 | 24.9 | 23% |
| 2021 | 170,996,190 | 52,643,221 | 118,352,969 | 74.7 | 33% |
| 2022 | 32,769,137 | 62,241,652 | −29,472,515 | 48.1 | 28% |
| 2023 | 23,662,636 | 42,903,351 | −19,240,715 | 56.6 | 23% |
In its most recent public year (2023), this organization spent $19,240,715 more than it brought in. Its reserves stood at about 56.6 months of spending, up from 0.8 in 2015. Staff pay was 23% of spending. $8,094,186 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works